Presentation TCT 2014 Updates from PARTNER 2A and Sapien 3 in Intermediate-Risk Patients Presenter: Martin B. Leon, Neil E. Moat, Ariel Finkelstein, Vinod H. Thourani September 13, 2014
Presentation TCT 2013 Lessons Learned from PARTNER 2A and SURTAVI: Device Specificity, Trial Design, Endpoints, and Future Low-risk Studies Presenter: Jodi Akin October 30, 2013
Presentation TCT 2013 Status Update on the Randomized Moderate Risk AS Trials: PARTNER 2A Presenter: Martin Leon October 27, 2013
Presentation TCT 2012 Update from the Randomized PARTNER 2A Trial Presenter: Martin Leon October 22, 2012
Video » Interview Dr. C. Michael Gibson Talks With Dr. Vinod Thourani About PARTNER 2A: 5-Year Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis September 28, 2019
Video » Interview TCT 2017: Dr. C. Michael Gibson talks with Dr. David Cohen about PARTNER 2A and SAPIEN 3 Cost-effectiveness May 11, 2018